Xindong Biotechnology

Beijing Xindong Biotechnology Co., Ltd. is a specialized biotechnology firm headquartered in Beijing, China, dedicated to the field of regenerative medicine and tissue engineering. The company focuses on the development and commercialization of bio-engineered solutions for ophthalmology, most notably its proprietary decellularized porcine corneal stroma. This product, marketed under the Xindong brand, provides a biological scaffold that facilitates the regeneration of the patient's own corneal tissue, offering a viable alternative to scarce human donor corneas. Xindong Biotechnology utilizes advanced decellularization and antigen-removal technologies to ensure high biocompatibility and transparency in its grafts. The company's portfolio aims to address significant unmet needs in treating corneal blindness and other ocular surface disorders.